GOSSAMER BIO INC's ticker is GOSS and the CUSIP is 38341P102.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,438,424 | +30.8% | 6,530,288 | +88.5% | 0.52% | +53.3% |
| Q2 2023 | $4,158,182 | -4.8% | 3,465,152 | 0.0% | 0.34% | -7.2% |
| Q1 2023 | $4,366,092 | +5229.8% | 3,465,152 | +9079.2% | 0.36% | +5071.4% |
| Q4 2022 | $81,918 | -99.6% | 37,750 | -97.8% | 0.01% | -99.6% |
| Q3 2022 | $20,973,000 | +43.1% | 1,750,651 | 0.0% | 1.66% | +29.8% |
| Q2 2022 | $14,653,000 | -3.9% | 1,750,651 | -0.3% | 1.28% | +8.3% |
| Q1 2022 | $15,249,000 | -24.0% | 1,756,757 | -0.9% | 1.18% | -8.0% |
| Q4 2021 | $20,052,000 | -10.0% | 1,772,950 | 0.0% | 1.28% | -4.8% |
| Q3 2021 | $22,286,000 | +54.8% | 1,772,950 | 0.0% | 1.34% | +69.6% |
| Q2 2021 | $14,396,000 | -12.2% | 1,772,950 | 0.0% | 0.79% | -15.1% |
| Q1 2021 | $16,400,000 | -2.5% | 1,772,950 | +1.9% | 0.93% | +5.9% |
| Q4 2020 | $16,817,000 | +25.8% | 1,739,050 | +61.4% | 0.88% | +20.2% |
| Q3 2020 | $13,368,000 | +403.5% | 1,077,200 | +427.5% | 0.73% | +361.6% |
| Q2 2020 | $2,655,000 | – | 204,214 | – | 0.16% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Omega Fund Management, LLC | 4,275,726 | $43,399,000 | 17.96% |
| Boxer Capital, LLC | 2,185,000 | $22,178,000 | 1.51% |
| HHLR ADVISORS, LTD. | 5,911,541 | $60,002,000 | 0.81% |
| Artal Group S.A. | 1,808,968 | $18,361,000 | 0.78% |
| CLOUGH CAPITAL PARTNERS L P | 459,834 | $4,667,000 | 0.46% |
| Spark Investment Management LLC | 39,906 | $405,000 | 0.22% |
| Alyeska Investment Group, L.P. | 476,838 | $4,840,000 | 0.10% |
| Cormorant Asset Management, LP | 198,382 | $2,014,000 | 0.09% |
| GSA CAPITAL PARTNERS LLP | 36,101 | $366,000 | 0.09% |
| Redmile Group, LLC | 259,700 | $2,636,000 | 0.07% |